Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Non-Current Debt (2016 - 2021)

Historic Non-Current Debt for Veracyte (VCYT) over the last 9 years, with Q3 2021 value amounting to $1.1 million.

  • Veracyte's Non-Current Debt rose 4219.58% to $1.1 million in Q3 2021 from the same period last year, while for Sep 2021 it was $1.1 million, marking a year-over-year increase of 4219.58%. This contributed to the annual value of $810000.0 for FY2020, which is 1671.47% up from last year.
  • Latest data reveals that Veracyte reported Non-Current Debt of $1.1 million as of Q3 2021, which was up 4219.58% from $917000.0 recorded in Q2 2021.
  • Over the past 5 years, Veracyte's Non-Current Debt peaked at $25.2 million during Q3 2018, and registered a low of $585000.0 during Q2 2019.
  • For the 5-year period, Veracyte's Non-Current Debt averaged around $11.6 million, with its median value being $1.1 million (2021).
  • Per our database at Business Quant, Veracyte's Non-Current Debt tumbled by 9766.96% in 2019 and then surged by 4219.58% in 2021.
  • Veracyte's Non-Current Debt (Quarter) stood at $24.9 million in 2017, then fell by 4.06% to $23.9 million in 2018, then plummeted by 97.1% to $694000.0 in 2019, then grew by 16.71% to $810000.0 in 2020, then skyrocketed by 32.72% to $1.1 million in 2021.
  • Its Non-Current Debt was $1.1 million in Q3 2021, compared to $917000.0 in Q2 2021 and $863000.0 in Q1 2021.